Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (nash) in five european countries in 2018: A cost-of-illness analysis
JM Schattenberg*, JV Lazarus*, PN Newsome, L Serfaty, A Aghemo, S Augustin, E Tsochatzis, VD Ledinghen, E Bugianesi, M Romero-Gomez, H Bantel, SD Ryder, J Boursier, V Leroy, J Crespo, L Castera, L Floros, V Atella, J Mestre-Ferrandiz, R ElliottA Kautz, A Morgan*, S Hartmanis, S Vasudevan, L Pezzullo, A Trylesinski, S Cure, V Higgins, V Ratziu
Research output: Contribution to journal › Article › peer-review
61Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (nash) in five european countries in 2018: A cost-of-illness analysis'. Together they form a unique fingerprint.